January 4, 2018 / 9:13 PM / 19 days ago

BRIEF-Alnylam Says‍ Expanded Alnylam Act Program To Include No-Charge Third-Party Genetic Testing For People At Risk For Acute Hepatic Porphyrias​

Jan 4 (Reuters) - Alnylam Pharmaceuticals Inc:

* ALNYLAM -‍ EXPANDS ALNYLAM ACT PROGRAM TO INCLUDE NO-CHARGE THIRD-PARTY GENETIC TESTING AND COUNSELING FOR PEOPLE AT RISK FOR ACUTE HEPATIC PORPHYRIAS​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below